Mar Cor Purification, Inc., a subsidiary of Cantel Medical Corp. (CMN), recently received approval from the FDA for its MINNCARE HD high level disinfectant.
MINNCARE HD disinfectant, a combination of peracetic acid and hydrogen peroxide, is biodegradable in nature, which allows easy disposal and helps to reduce adverse environmental impact.
Interestingly, MINNCARE Cold Sterilant, the non-medical device version, is used in a variety of markets and applications on a daily basis.
Along with MINNCARE HD disinfectant, Mar Cor will provide validated test strips which will be used for testing strength. At the same time, they will help eliminate the presence of any residuals following a disinfection procedure. Both these products are expected to be available in early Feb 2015.
MINNCARE HD disinfectant is designed to obliterate the risk of using unregulated industrial chemicals, such as chlorine bleach, in treatment areas.
We believe such new products will complement the existing product portfolio of Mar Cor and help drive significant top-line growth at the company, going forward. The prospective product roll-outs particularly underscore Cantel Medical’s initiatives to strengthen the Mar Cor Purification division.
Cantel Medical recently acquired water purification and treatment service provider Pure Water Solutions for $11.9 million in cash. Pure Water Solutions will be integrated into Cantel Medical’s Mar Cor Purification division, which happens to be one of the largest suppliers of dialysis medical water systems in North America.
Zacks Rank
Stocks that warrant a look in the medical instruments sector are Inogen (INGN), Synergetics USA (SURG) and ABIOMED (ABMD). While Inogen and Synergetics sport a Zacks Rank #1 (Strong Buy), ABIOMED carries a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Be the first to comment